# The Fibrin Pad Cardiovascular Study

> **NCT01681030** · PHASE2 · COMPLETED · sponsor: **Ethicon, Inc.** · enrollment: 42 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **BIOLOGICAL:** EVARREST™
- **BIOLOGICAL:** Topical hemostat
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT01681030
- **Lead sponsor:** Ethicon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-01
- **Primary completion:** 2013-08-01
- **Final completion:** 2013-09-03
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01681030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01681030, "The Fibrin Pad Cardiovascular Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01681030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*